Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Ra­tio Ther­a­peu­tics rais­es $70M in a Se­ries C fund­ing round, with participation from ex­ist­ing in­vestors Duquesne Fam­i­ly. The funds will support their ra­dio­phar­ma­ceutical tri­als.

PRIVATEJul 31, 2026•9 days ago

Amount Raised

$70 Million

Round Type

Series C

BostonBiotechnologyHealth Care

Investors

Duquesne Family

Description

Ra­tio Ther­a­peu­tics has successfully closed a $70 million Series C funding round. This financing comes from existing investors, including Duquesne Family. The raised capital will be utilized for their radio­pharmaceutical trials. This marks a significant milestone for the Boston-based biotech.

Company Information

Company

Ra­tio Ther­a­peu­tics

Location

Boston, Massachusetts, United States

About

Ra­tio Ther­a­peu­tics is a Boston-based biotechnology company focused on developing radiopharmaceuticals. They are dedicated to advancing innovative treatments for patients through their research and clinical trials. The company recently raised $70M in Series C funding to support their ongoing radiopharmaceutical trials.

Predictive Intelligence
Strategic

ML-powered predictions for Ra­tio Ther­a­peu­tics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.